For research use only. Not for therapeutic Use.
Enfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab can used for researching urothelial cancer[1].
| Catalog Number | I043782 |
| CAS Number | 1448664-46-7 |
| Purity | ≥95% |
| Reference | [1]. Rosenberg JE, et al. Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy. J Clin Oncol. 2019;37(29):2592-2600. |
